" class="wow_main_float_head_img">
Transplantation Industry Overview
The global transplantation market size was estimated at USD 12.4 billion in 2021 and is anticipated to expand at a CAGR of 9.4% during the forecast period.
Growing demand for novel tissue transplantation products and organ transplantation for the treatment of organ failure is a major factor contributing to the market growth. Organ failure usually occurs due to various factors such as serious trauma, loss of blood, poisoning, drug abuse, leukemia, sepsis, and other acute diseases. Demand for tissue and organ transplantation, mainly kidney, heart, liver, and lungs, is very high globally. Unhealthy dietary habits, alcohol consumption, lack of exercise, and drug abuse are some leading causes of organ failure. Thus, demand for transplantation products is expected to rise in the near future.
Gather more insights about the market drivers, restrains and growth of the Global Transplantation Market
After a transplantation surgery, the recipients are prescribed powerful immunosuppressive drugs; thus, increasing their susceptibility to infectious diseases as their immunity is weakened. This can be attributed to the decline in transplantation numbers in many countries amid the COVID-19 situation. Moreover, the shortage of resources such as primary protective equipment, ICU, and blood products during the pandemic has contributed to the sharp fall in the market’s revenue in 2021.
The global increase in the demand for organs for transplant can be attributed to an increase in the incidence of acute diseases, which in turn results in an increase in the number of organ failures. For instance, diabetes and high blood pressure are the most common causes of end-stage renal disease, where kidney transplants or dialysis are the only treatment options to keep a patient alive. According to the U.S. Department of Health Human Services, there were around 122,913 patients in the U.S. waiting to receive organs for transplant in 2019. Thus, there are high demand for advanced transplantation products for the treatment of organ failure.
Some of the major driving factors impacting the market include the introduction of technologically advanced products and an increasing number of tissue banks. However, some of the factors such as the shortage of organ donors for transplantation procedures are expected to restrain the market growth. There is a huge gap between the demand and supply of organs for organ failure treatment. According to the U.S. Department of Health Human Services, in 2019, there were around 43,201 patients waiting for kidney transplants in the U.S. However, only 23,401 kidney transplant procedures were performed in 2019. Lack of awareness for organ donation and religious customary beliefs prevent a large number of people from donating. Thus, the shortage of organs for the treatment of organ failure is expected to adversely affect the market growth.
Browse through Grand View Research's Medical Devices Industry Research Reports.
- Transplant Box Market - The global transplant box market size was valued at USD 7.5 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 8.6% from 2020 to 2027. Rising cases of multiple organ failure coupled with an increasingly aging population are the major factors driving the growth of the market for transplant boxes.
- Transplant Diagnostics Market - The global transplant diagnostics market size was valued at USD 500.1 million in 2016 and is likely to expand at a CAGR of 7.6% over the forecast period. Increasing organ transplants is a major factor driving demand for diagnostics used before the procedure. The demand for transplants has always been higher than the supply of organs.
Transplantation Market Segmentation
Grand View Research has segmented the global transplantation market on product, application, end-use, and region:
Product Outlook (Revenue, USD Billion; 2018 - 2030)
- Tissue Products
- Immunosuppressive Drugs
- Preservation Solution
Application Outlook (Revenue, USD Billion; 2018 - 2030)
- Organ Transplantation
- Tissue Transplantation
End Use Outlook (Revenue, USD Billion; 2018 - 2030)
- Hospitals
- Transplant Centers
- Others
Regional Outlook (Revenue, USD Billion; 2018 - 2030)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East Africa
Market Share Insights
- September 2020: Israel-based CollPlant Biotechnologies and United therapeutics announced a collaboration to include 3D bioprinting in the development of human kidneys for transplant.
- May 2020: AbbVie announced the acquisition of Allergan to strengthen its product portfolio and distribution channels.
- September 2015: Arthrex Inc. launched ArthroFlex Acellular Dermal Matrix, a new orthobiologic product that is intended for use in capsular reconstruction.
Key Companies profiled:
Some prominent players in the global transplantation market include
- AbbVie, Inc.
- Arthrex, Inc.
- Zimmer Biomet
- Medtronic
- Novartis AG
- Stryker
- 21st Century Medicine
- BioLifeSolutions, Inc
- Teva Pharmaceuticals
- Veloxis Pharmaceuticals
Order a free sample PDF of the Transplantation Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
